RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mochida Pharmaceutical Co Stock

Mochida Pharmaceutical Co Stocks 2024

Mochida Pharmaceutical Co Stocks

35.86 M

Ticker

4534.T

ISIN

JP3922800002

WKN

859288

In 2024, Mochida Pharmaceutical Co had 35.86 M outstanding stocks, a -3.49% change from the 37.16 M stocks in the previous year.

The Mochida Pharmaceutical Co Stocks history

YEARNUMBER OF STOCKS (undefined JPY)
2027e35.86
2026e35.86
2025e35.86
202435.86
202337.16
202238.1
202138.63
202039.12
201939.63
201839.7
201739.71
201639.71
201539.99
201440
201341
201242
201144
201045
200947
200848
200749
200650
200551

Mochida Pharmaceutical Co shares outstanding

The number of shares was Mochida Pharmaceutical Co in 2023 — This indicates how many shares 37.16 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Mochida Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Mochida Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Mochida Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Mochida Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Mochida Pharmaceutical Co Aktienanalyse

What does Mochida Pharmaceutical Co do?

Mochida Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company has been in the industry for over 100 years and has become one of the leading providers of medications and health products in Japan and worldwide. The history of Mochida Pharmaceutical begins in 1913 when Shoyo Mochida founded the company. Initially, the company specialized in the production of vitamins and later expanded its product range to include other pharmaceutical products. Over the following decades, the company steadily grew and expanded internationally. Today, Mochida Pharmaceutical is involved in various areas of healthcare. The company offers a wide range of medications for the treatment of various diseases and ailments, including cardiovascular diseases, diabetes, cancer, infectious diseases, and mental illnesses. Mochida Pharmaceutical is also involved in other areas of healthcare. The company manufactures and distributes various medical devices and diagnostics, including a wide range of medical instruments such as endoscopes and ultrasound devices, as well as tests and reagents for the diagnosis of infectious diseases and other conditions. A major focus of Mochida Pharmaceutical's business model is research and development of new products. The company has an extensive research and development department that continuously works on the development of new medications and technologies. Mochida Pharmaceutical collaborates closely with various universities and research institutes to develop new insights and technologies. In addition to the production and distribution of medications and medical devices, Mochida Pharmaceutical is also engaged in health promotion and prevention. The company offers various health services and products aimed at helping people live healthier lives and take better care of their health. Over the years, the company has achieved several important milestones. In 1970, Mochida Pharmaceutical successfully developed an immunosuppressive medication that is now known as Tacrolimus and is used to prevent organ transplant rejection. Other significant milestones include the introduction of medications for the treatment of diabetes and cancer, as well as the development of new technologies such as transdermal patches for medication administration. Mochida Pharmaceutical is now a globally operating company with branches in various countries. The company employs thousands of employees worldwide and has a strong presence in all major markets. The company is committed to further expanding its position as a leading provider of medical products and services and focusing on the needs of its customers and patients. Mochida Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Mochida Pharmaceutical Co's Shares Outstanding

Mochida Pharmaceutical Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Mochida Pharmaceutical Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Mochida Pharmaceutical Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Mochida Pharmaceutical Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Mochida Pharmaceutical Co stock

How many stocks are there of Mochida Pharmaceutical Co?

The current number of stocks of Mochida Pharmaceutical Co is 35.86 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Mochida Pharmaceutical Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Mochida Pharmaceutical Co evolved in recent years?

The number of shares of Mochida Pharmaceutical Co has increased by -3.49% gesunken compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Mochida Pharmaceutical Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Mochida Pharmaceutical Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Mochida Pharmaceutical Co pay?

Over the past 12 months, Mochida Pharmaceutical Co paid a dividend of 80 JPY . This corresponds to a dividend yield of about 2.38 %. For the coming 12 months, Mochida Pharmaceutical Co is expected to pay a dividend of 83.96 JPY.

What is the dividend yield of Mochida Pharmaceutical Co?

The current dividend yield of Mochida Pharmaceutical Co is 2.38 %.

When does Mochida Pharmaceutical Co pay dividends?

Mochida Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Mochida Pharmaceutical Co?

Mochida Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Mochida Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 83.96 JPY are expected. This corresponds to a dividend yield of 2.5 %.

In which sector is Mochida Pharmaceutical Co located?

Mochida Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mochida Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mochida Pharmaceutical Co from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Mochida Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Mochida Pharmaceutical Co in the year 2023?

In the year 2023, Mochida Pharmaceutical Co distributed 80 JPY as dividends.

In which currency does Mochida Pharmaceutical Co pay out the dividend?

The dividends of Mochida Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mochida Pharmaceutical Co

Our stock analysis for Mochida Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mochida Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.